Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Turning Diagnostic Contracts into Manufacturing Matters for FTSE AIM All-Share Firm Abingdon Health (ABDX)

Rather than relying on a single test of its own, Abingdon offers services to other companies, helping them design, develop and manufacture lateral-flow tests across health, veterinary, environmental and other applications. This positions it as a picks-and-shovels supplier to the diagnostics industry, earning fees …

Ankur Sharma | 21 September 2026

How Synthetic DNA Could Shape the Next Chapter for 4basebio (4BB), a FTSE AIM All-Share Company

Traditional DNA used in advanced therapies has often been produced in bacteria, a process that can be slow and that carries regulatory complications. 4basebio's proposition is enzymatic, cell-free synthetic DNA, produced to a defined sequence without bacterial fermentation, alongside synthetic delivery vehicles such as …

Ankur Sharma | 21 September 2026

Why Did AstraZeneca PLC LSE:AZN Rise 1.06% Amid a firmer tone across London-listed pharmaceutical shares?

AstraZeneca PLC — LSE:AZN closed 1.06% higher on18 September 2026, with the shares at 12,560.00p after a gain of 132.00p on the day.

Ishan Mudgal | 18 September 2026

Why Did Smith & Nephew PLC LSE:SN. Fall 0.10% Amid a softer tone across London-listed medical technology shares?

Smith & Nephew PLC — LSE:SN. closed 0.10% lower on18 September 2026, with the shares at 1,034.50p after a fall of 1.00p on the day.

Ishan Mudgal | 18 September 2026

Why Did ConvaTec Group PLC LSE:CTEC Fall 1.37% Amid a softer tone across London-listed medical technology shares?

ConvaTec Group PLC — LSE:CTEC closed 1.37% lower on18 September 2026, with the shares at 215.60p after a fall of 3.00p on the day.

Ishan Mudgal | 18 September 2026

Why Did GSK PLC LSE:GSK Fall 0.84% Amid a softer tone across London-listed pharmaceutical shares?

GSK PLC — LSE:GSK closed 0.84% lower on18 September 2026, with the shares at 1,884.00p after a fall of 16.00p on the day.

Ishan Mudgal | 18 September 2026

Why Did Haleon PLC LSE:HLN Rise 0.50% Amid a firmer tone across London-listed consumer health shares?

Haleon PLC — LSE:HLN closed 0.50% higher on18 September 2026, with the shares at 341.40p after a gain of 1.70p on the day.

Ishan Mudgal | 18 September 2026

What Could Make Diagnostic Testing a Stronger Earnings Engine for FTSE AIM’s EKF Diagnostics (LSE:EKF)?

EKF Diagnostics, listed on London’s AIM, develops and manufactures point-of-care diagnostic devices and related products, alongside a life-sciences business. Its point-of-care analysers measure markers such as haemoglobin, glucose and other indicators quickly at the patient’s side, used in clinics, hospitals and health programmes worldwide. …

Ankur Sharma | 18 September 2026

Why Clinical Applications Could Shape FTSE 250 Life Sciences Stock Oxford Nanopore (LSE:ONT)

Clinical applications could shape Oxford Nanopore (LSE:ONT) because moving its DNA and RNA sequencing technology from the research bench into hospitals and diagnostics is the company's clearest route to faster growth and, eventually, profit. Clinical work commands higher volumes and more repeatableDemandthan one-off research …

Ankur Sharma | 18 September 2026

CVS Group Eases Back: Veterinary Sector Regulation Still Looming

CVS Group PLC (LSE:CVSG) shares fell -0.15% today, based on the supplied market data. The shares last traded at 1316.00p, down -2.00 on the day.

Divya Sood | 18 September 2026
Support

Hi! How can we help you today?

Loading…